<DOC>
	<DOC>NCT00365300</DOC>
	<brief_summary>To assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD).</brief_summary>
	<brief_title>Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>term or post term infants beyond the neonatal period of an age greater than 28 days but less than or equal to 11 months clinical diagnosis of GERD weight greater than 2.5 kg and less than or equal to 15 kg known history of upper GI anatomic disorders history of acute lifethreatening medical conditions clinically significant medical conditions or laboratory abnormalities</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>11 Months</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>GERD</keyword>
	<keyword>Infants</keyword>
	<keyword>Gastroesophageal Reflux</keyword>
</DOC>